Cargando…
The Metabolic Fingerprint of Doxorubicin-Induced Cardiotoxicity in Male CD-1 Mice Fades Away with Time While Autophagy Increases
The cardiotoxicity of doxorubicin (DOX) may manifest at the beginning/during treatment or years after, compromising patients’ quality of life. We intended to study the cardiac pathways one week (short-term, control 1 [CTRL1] and DOX1 groups) or five months (long-term, CTRL2 and DOX2 groups) after DO...
Autores principales: | Brandão, Sofia Reis, Reis-Mendes, Ana, Neuparth, Maria João, Carvalho, Félix, Ferreira, Rita, Costa, Vera Marisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675798/ https://www.ncbi.nlm.nih.gov/pubmed/38004479 http://dx.doi.org/10.3390/ph16111613 |
Ejemplares similares
-
Cardiac Molecular Remodeling by Anticancer Drugs: Doxorubicin Affects More Metabolism While Mitoxantrone Impacts More Autophagy in Adult CD-1 Male Mice
por: Brandão, Sofia Reis, et al.
Publicado: (2023) -
The role of inflammation and antioxidant defenses in the cardiotoxicity of doxorubicin in elderly CD-1 male mice
por: Reis-Mendes, Ana, et al.
Publicado: (2023) -
Doxorubicin Is Key for the Cardiotoxicity of FAC (5-Fluorouracil + Adriamycin + Cyclophosphamide) Combination in Differentiated H9c2 Cells
por: Pereira-Oliveira, Maria, et al.
Publicado: (2019) -
Role of Inflammation and Redox Status on Doxorubicin-Induced Cardiotoxicity in Infant and Adult CD-1 Male Mice
por: Reis-Mendes, Ana, et al.
Publicado: (2021) -
Fuch's Heterochromic Iridocyclitis in Iran: Is the Disease Going to Fade Away?
por: Piri, Niloofar, et al.
Publicado: (2015)